Immatics at The International Conference on Lymphocyte Engineering (Sept 13-15) in London, UK
Health innovators in immune-gene therapy coming together
Meet Immatics at this year’s ICLE, discuss engineering approaches and get a dedicated ACTallo® update:
Saturday, Sept 14, 12.20pm – 12.35pm UK time
Session 4: TCR for the treatment of solid tumors
ACTallo®: Using TCR-engineered allogeneic gamma-delta T cells to treat cancer
Speaker: Mamta Kalra, Assoc. Director CMC
Further information on ICLE 2019 here.